课题基金 / 基金详情

Molecular mechanisms of SCLC initiation and detection in mice and humans

Molecular mechanisms of SCLC initiation and detection in mice and humans
小鼠和人类 SCLC 启动和检测的分子机制
批准号:
10469595
负责人:
MARK A KRASNOW
金额:
$53.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-19 至 2024-08-31

项目摘要

项目成果

MARK A KRASNOW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Small cell lung carcinoma (SCLC) is one of the deadliest cancers, a “recalcitrant” cancer for which there is no effective treatment except when the disease is diagnosed early. However, only a small fraction of patients are diagnosed early in disease. The greatest challenge to early diagnosis is that SCLC tumor cells typically acquire an exceptional mutation burden and metastasize early, so for most patients disease has spread beyond the lung at the time of diagnosis. The key to developing effective early diagnosis and treatment methods is to elucidate the earliest molecular and cellular events of tumor initiation to uncover ones that can be detected by screening during the premalignant phase of the disease. The goal of this proposal is to define the early, premalignant molecular and cellular events of SCLC, so that they can be detected early and destroyed before they become a deadly, untreatable disease. SCLC is a neuroendocrine cancer. The prominent cell of origin is pulmonary neuroendocrine (NE) cells, neurosensory and neurosecretory epithelial cells that sense and respond to the environment in the lung. Recently, a minor subpopulation of NE cells was found to have stem cell activity, proliferating, dispersing, and replenishing the surrounding bronchial epithelium following severe airway injury. Loss of tumor suppressors Rb and p53 constitutively activates the stem cell program within days of loss of the tumor suppressors, even in the absence of injury. In this proposal, a combination of genetics, cell culture, and single-cell genomics is used to systematically interrogate these stem cells at cellular resolution, both in healthy lungs and in the early, premalignant stage of SCLC. The goal is to define the molecular events immediately following loss of Rb and p53 that constitutively activate the stem cell program and initiate their transformation into cancer stem cells that spread, mutate, and escape immune destruction, and to identify the signals they secrete that might allow the tumors to be detected before they become deadly.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.7554/elife.78216
发表时间: 2022-12-05
期刊: eLife
影响因子: 7.7
作者: [Kuo CS, Darmanis S, Diaz de Arce A, Liu Y, Almanzar N, Wu TT, Quake SR, Krasnow MA]
通讯作者: Krasnow MA
Molecular mechanisms of SCLC initiation and detection in mice and humans
  • 批准号:
    10245149
  • 项目类别:
  • 资助金额:
    $56.75万
  • 财政年份:
    2018
  • 负责人:
    MARK A KRASNOW
  • 依托单位:
Molecular mechanisms of SCLC initiation and detection in mice and humans
  • 批准号:
    9788319
  • 项目类别:
  • 资助金额:
    $57.31万
  • 财政年份:
    2018
  • 负责人:
    MARK A KRASNOW
  • 依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
  • 批准号:
    8114057
  • 项目类别:
  • 资助金额:
    $101.61万
  • 财政年份:
    2009
  • 负责人:
    MARK A KRASNOW
  • 依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
  • 批准号:
    7833775
  • 项目类别:
  • 资助金额:
    $102.18万
  • 财政年份:
    2009
  • 负责人:
    MARK A KRASNOW
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: